Ron Ofri, DVM, PhD, DECVO

Professor of Veterinary Ophthalmology
Koret School of Veterinary Medicine
Hebrew University of Jerusalem

The eye is a horribly-designed optical instrument. Emmetropia and ametropia in our patients

It can be argued that the entire purpose of the eye is to focus light on a functioning retina. However, because of variations in ocular anatomy and numerous physical aberrations, this goal is often elusive. Therefore, it is no wonder that the foremost optics scientist of the 19th century, Hermann von Helmholtz, inventor of the ophthalmoscope, thought the optical design of the eye is horrible. In this talk, we shall review the obstacles in the pathway of light to the retina, and how they can be overcome.

Everything you ever wanted to know about ERG but were afraid to ask

In this talk, we shall discuss how to prepare your patient for an ERG recording, the equipment needed, and the protocols and settings recommended for a diagnostic recording. Tips on reducing noise and coping with other technical problems will also be reviewed. The most common mistakes and myths will be discussed as well, and attendees will get many practical tips and plenty of advice on how to record and interpret an ERG.

Speaker

Ron Ofri, DVM, PhD, DECVO

Ron Ofri was a member of the charter class of the Koret School of VeterinarMedicine, Hebrew University of Jerusalem, Israel. Upon his graduation he traveled to the University of Florida, where he spent the next 4 years undergoing clinical training in veterinary ophthalmology and obtaining his Ph.D. During this time Ron developed an interest in the physiology of vision, focusing on retinal electrophysiology and animal models of retinal diseases. Upon his graduation Ron returned to Israel and joined the faculty of his alma mater, where he is currently a Professor in Veterinary Ophthalmology and winner of numerous Teacher of the Year awards. At the Hebrew University of Jerusalem, Ron expanded his research interests to include to include clinical veterinary ophthalmology (focusing on glaucoma and retinal diseases) and retinal gene therapy. His groundbreaking work on retinal gene therapy on a herd of sheep with naturally occurring day blindness has resulted in restoration of vision in treated animals for >6 years, and has paved the way to FDA approval of Phase I/IIa clinical trials in humans patients. Ron is also a very popular international speaker, having been invited to talk in more than 40 countries and 6 continents, lecturing in continuing education seminars, national & international meetings, and world congresses for general practitioners including BSAVA, SEVC, WSAVA, WVC, WVAC and NAVC/VMX.